Research · Sep 3, 2026
[ADM] Archer-Daniels-Midland Thesis 2026: Nutrition Restatement Aftermath Tests Agribusiness Cycle Recovery
Archer-Daniels-Midland Company FY2025 revenue ~$84-86B (-3 to -1%) with adj. EPS ~$3.80-4.20 reflecting continued post-2022-2023 commodity cycle moderation (selected post-Russia/Ukraine grain price normalization + selected ethanol margin compression + selected oilseed crush margin normalization) + continued post-January 22, 2024 accounting restatement aftermath (Nutrition segment intersegment sales SEC investigation + selected ~$200M+ restatement adjustments) + selected operational excellence under continued CEO Juan Luciano. Leading global agribusiness firm; founded 1902 by John W. Daniels in Minneapolis Minnesota originally as Daniels Linseed Company (later merged with Archer-Daniels Linseed Company 1923 to form Archer-Daniels-Midland Company; IPO 1924); headquartered in Chicago Illinois (corporate HQ moved from Decatur Illinois 2014; substantial Decatur + Chicago + selected operations); ~38,000+ employees across selected ~200+ countries. 3 segments + Other: Ag Services & Oilseeds 62% ($53B — origination grain trading + crushing oilseed soybean/canola/sunflower + refined products refined oils + biodiesel; ~$2.5-3.0B segment operating profit) + Carbohydrate Solutions 24% ($20B — Starches & Sweeteners HFCS + glucose syrups + Vantage Corn Processors ethanol + selected industrial corn; ~$0.8-1.0B operating profit) + Nutrition 12% ($10B — Human Nutrition selected ingredient blends + flavor solutions + Animal Nutrition; selected post-2014 Wild Flavors $3B + Neovia 2019 $1.85B acquisitions; ~$0.5-0.7B operating profit post-restatement) + Other 2% ($1B). January 22, 2024 Accounting Restatement Scandal: ADM disclosed that it would delay Q4 2023 earnings release amid SEC investigation into intersegment sales accounting practices in the Nutrition segment; CFO Vikram Luthar placed on administrative leave (subsequently resigned March 2024); company restated 2018-2023 financials with selected ~$200M+ cumulative adjustments to Nutrition segment operating profit (selected intersegment transfer pricing inflated Nutrition margins; selected actual Nutrition organic margins materially lower than originally reported); selected ongoing SEC investigation + selected DOJ inquiry + selected shareholder litigation; impacted FY2024 stock price (~25-30% decline post-disclosure). CEO Juan Luciano since January 1, 2015 (succeeded Patricia Woertz CEO 2006-2015 retired; Luciano ex-ADM President + COO 2014-2015 + ex-Dow Chemical Performance Materials EVP 2009-2011 + ~30-year industrial chemicals + commodities executive career; Argentine national). Capital return: dividend $2.00-2.04/share annual (~50 consecutive year increases — Dividend King 50+) + buybacks $0.5-1.5B; investment-grade A2/A credit rating. FY2026 thesis: Nutrition restatement aftermath resolution + agribusiness cycle recovery + capital return + Dividend King continuity. Risks: agribusiness commodity cyclicality, continued SEC/DOJ investigation findings, tariff/trade exposure, weather/agricultural cycle, Bunge-Viterra merger competitive pressure (~$8.2B merger pending July 2025).